Terms: = Colorectal cancer AND KRAS, C-K-RAS, 3845, P01116, NS3, KI-RAS, KRAS2, K-RAS4A, K-RAS2A, K-RAS4B, KRAS1, K-RAS2B, RASK2 AND Diagnosis
551 results:
1. Temporal trends and regional variability in BRAF and kras genetic testing in Denmark (2010-2022): Implications for precision medicine.
Frost MG; Jensen KJ; Jimenez-Solem E; Qvortrup C; Kuhlmann TP; Andersen JL; Høgdall E; Petersen TS
Genes Chromosomes Cancer; 2024 Apr; 63(4):e23236. PubMed ID: 38656617
[TBL] [Abstract] [Full Text] [Related]
2. [colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological analysis of eight cases].
Wang Q; Zhang Y; Tan C; Ni SJ; Huang D; Chang B; Sheng WQ; Wang L
Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):370-376. PubMed ID: 38556821
[No Abstract] [Full Text] [Related]
3. Circular RNAs in the kras pathway: Emerging players in cancer progression.
Hussain MS; Moglad E; Afzal M; Bansal P; Kaur H; Deorari M; Ali H; Shahwan M; Hassan Almalki W; Kazmi I; Alzarea SI; Singh SK; Dua K; Gupta G
Pathol Res Pract; 2024 Apr; 256():155259. PubMed ID: 38503004
[TBL] [Abstract] [Full Text] [Related]
4. Noninvasive Stratification of Colon cancer by Multiplex PET Imaging.
Malviya G; Lannagan TRM; Johnson E; Mackintosh A; Bielik R; Peters A; Soloviev D; Brown G; Jackstadt R; Nixon C; Gilroy K; Campbell A; Sansom OJ; Lewis DY
Clin Cancer Res; 2024 Apr; 30(8):1518-1529. PubMed ID: 38493804
[TBL] [Abstract] [Full Text] [Related]
5. Efficacy of Chemotherapy Rechallenge Versus Regorafenib or Trifluridine/Tipiracil in Third-Line Setting of Metastatic colorectal cancer: A Multicenter Retrospective Comparative Study.
Bazarbashi S; Alkhatib R; Aseafan M; Tuleimat Y; Abdel-Aziz N; Mahrous M; Elsamany S; Elhassan T; Alghamdi M
JCO Glob Oncol; 2024 Mar; 10():e2300461. PubMed ID: 38484194
[TBL] [Abstract] [Full Text] [Related]
6. Twelve-month progression-free survival with sotorasib and panitumumab in kras G12C mutant metastatic colorectal cancer.
Kavgaci G; Dizdar O; Yalcin S
Anticancer Drugs; 2024 Jun; 35(5):459-461. PubMed ID: 38451823
[TBL] [Abstract] [Full Text] [Related]
7. Extended Enrichment for Ultrasensitive Detection of Low-Frequency Mutations by Long Blocker Displacement Amplification.
Si Y; Wang X; Su X; Weng Z; Hu Q; Li Q; Fan C; Zhang DY; Wang Y; Luo S; Song P
Angew Chem Int Ed Engl; 2024 May; 63(19):e202400551. PubMed ID: 38416545
[TBL] [Abstract] [Full Text] [Related]
8. Serum Tumor Markers and Outcomes in Patients With Appendiceal Adenocarcinoma.
Yousef A; Yousef M; Zeineddine MA; More A; Fanaeian M; Chowdhury S; Knafl M; Edelkamp P; Ito I; Gu Y; Pattalachinti V; Naini ZA; Zeineddine FA; Peterson J; Alfaro K; Foo WC; Jin J; Bhutiani N; Higbie V; Scally CP; Kee B; Kopetz S; Goldstein D; Strach M; Williamson A; Aziz O; Barriuso J; Uppal A; White MG; Helmink B; Fournier KF; Raghav KP; Taggart MW; Overman MJ; Shen JP
JAMA Netw Open; 2024 Feb; 7(2):e240260. PubMed ID: 38416491
[TBL] [Abstract] [Full Text] [Related]
9. Tumor location matters, next generation sequencing mutation profiling of left-sided, rectal, and right-sided colorectal tumors in 552 patients.
Ciepiela I; Szczepaniak M; Ciepiela P; Hińcza-Nowak K; Kopczyński J; Macek P; Kubicka K; Chrapek M; Tyka M; Góźdź S; Kowalik A
Sci Rep; 2024 Feb; 14(1):4619. PubMed ID: 38409377
[TBL] [Abstract] [Full Text] [Related]
10. Clinical and genetic factors associated with tumor response to neoadjuvant (chemo)radiotherapy, survival and recurrence risk in rectal cancer.
Hammarström K; Nunes L; Mathot L; Mezheyeuski A; Lundin E; Korsavidou Hult N; Imam I; Osterlund E; Sjöblom T; Glimelius B
Int J Cancer; 2024 Jul; 155(1):40-53. PubMed ID: 38376070
[TBL] [Abstract] [Full Text] [Related]
11. Clinical features and mutation analysis of class 1/2/3 BRAF mutation colorectal cancer.
Huang Y; Jia W; Zhao G; Zhao Y; Zhang S; Li Z; Wu G
Chin Clin Oncol; 2024 Feb; 13(1):3. PubMed ID: 38372057
[TBL] [Abstract] [Full Text] [Related]
12. Multi-omic profiling reveals associations between the gut microbiome, host genome and transcriptome in patients with colorectal cancer.
Zou S; Yang C; Zhang J; Zhong D; Meng M; Zhang L; Chen H; Fang L
J Transl Med; 2024 Feb; 22(1):175. PubMed ID: 38369542
[TBL] [Abstract] [Full Text] [Related]
13. Exploring the role of sporadic BRAF and kras mutations during colorectal cancer pathogenesis: A spotlight on the contribution of the endosome-lysosome system.
Tang J; Lam GT; Brooks RD; Miles M; Useckaite Z; Johnson IR; Ung BS; Martini C; Karageorgos L; Hickey SM; Selemidis S; Hopkins AM; Rowland A; Vather R; O'Leary JJ; Brooks DA; Caruso MC; Logan JM
Cancer Lett; 2024 Mar; 585():216639. PubMed ID: 38290660
[TBL] [Abstract] [Full Text] [Related]
14. DNA Marker in Stool Led to a Second High-Quality Colonoscopy Within Three Months and Removal of an Undetected High-Risk Polyp.
Franck S; Eidens M; Fuhrländer J; Ogreid D
Clin Lab; 2024 Jan; 70(1):. PubMed ID: 38213210
[TBL] [Abstract] [Full Text] [Related]
15. kras Sequence Variation as Prognostic Marker in Patients With Young- vs Late-Onset colorectal cancer.
Aljehani MA; Bien J; Lee JSH; Fisher GA; Lin AY
JAMA Netw Open; 2023 Nov; 6(11):e2345801. PubMed ID: 38032636
[TBL] [Abstract] [Full Text] [Related]
16. Driver gene kras aggravates cancer-associated stroke outcomes.
Yan H; Sasaki T; Gon Y; Nishiyama K; Kanki H; Mochizuki H
Thromb Res; 2024 Jan; 233():55-68. PubMed ID: 38029547
[TBL] [Abstract] [Full Text] [Related]
17. Sequencing paired tumor DNA and white blood cells improves circulating tumor DNA tracking and detects pathogenic germline variants in localized colon cancer.
Gimeno-Valiente F; Martín-Arana J; Tébar-Martínez R; Gambardella V; Martínez-Ciarpaglini C; García-Micó B; Martínez-Castedo B; Palomar B; García-Bartolomé M; Seguí V; Huerta M; Moro-Valdezate D; Pla-Martí V; Pérez-Santiago L; Roselló S; Roda D; Cervantes A; Tarazona N
ESMO Open; 2023 Dec; 8(6):102051. PubMed ID: 37951129
[TBL] [Abstract] [Full Text] [Related]
18. An incidental traditional serrated adenoma of the gallbladder: A case report.
Abecia Martínez EI; Ríos Ballestín G; Castillo Malla J; Martínez Arnau N; Hörndler Argarate C
Rev Esp Patol; 2023; 56(4):271-274. PubMed ID: 37879824
[TBL] [Abstract] [Full Text] [Related]
19. Do resected colorectal cancer patients need early chest imaging? Impact of clinicopathologic characteristics on time to development of pulmonary metastases.
Deboever N; Bayley EM; Eisenberg MA; Hofstetter WL; Mehran RJ; Rice DC; Rajaram R; Roth JA; Sepesi B; Swisher SG; Vaporciyan AA; Walsh GL; Bednarski BK; Morris VK; Antonoff MB
J Surg Oncol; 2024 Feb; 129(2):331-337. PubMed ID: 37876311
[TBL] [Abstract] [Full Text] [Related]
20. Oligo-metastatic neoPlasms from the gastro-intestinal tract: iDentIfiCaTIon of cliNical and molecular drivers: the PREDICTION study.
Ottaiano A; De Luca A; Santorsola M; Scognamiglio G; Di Mauro A; Chiodini P; Lambiase M; Sacco A; Petrillo A; Granata V; Fusco R; Mercadante E; Martucci N; De Luca G; Rocca A; Celentano E; Crispo A; Di Gennaro P; Tatangelo F; Ferrara G; Izzo F; Belli A; Patrone R; Delrio P; Rega D; De Franciscis S; Muto P; Ravo V; Di Franco R; Borzillo V; Santagata S; Rea G; Castaldo D; Pace U; De Feo G; Scala S; Nasti G; Normanno N
BMC Cancer; 2023 Oct; 23(1):1010. PubMed ID: 37858132
[TBL] [Abstract] [Full Text] [Related]
[Next]